Claire O'Callaghan - Publications

Affiliations: 
University of Cambridge, Cambridge, England, United Kingdom 

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ye R, Hezemans FH, O'Callaghan C, Tsvetanov KA, Rua C, Jones PS, Holland N, Malpetti M, Murley AG, Barker RA, Williams-Gray CH, Robbins TW, Passamonti L, Rowe JB. Locus coeruleus integrity is linked to response inhibition deficits in Parkinson's disease and progressive supranuclear palsy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 37669861 DOI: 10.1523/JNEUROSCI.0289-22.2023  0.479
2023 Orlando IF, Shine JM, Robbins TW, Rowe JB, O'Callaghan C. Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing. Neuroscience and Biobehavioral Reviews. 149: 105167. PMID 37054802 DOI: 10.1016/j.neubiorev.2023.105167  0.423
2022 Watson P, O'Callaghan C, Perkes I, Bradfield L, Turner K. Making habits measurable beyond what they are not: A focus on associative dual-process models. Neuroscience and Biobehavioral Reviews. 142: 104869. PMID 36108980 DOI: 10.1016/j.neubiorev.2022.104869  0.552
2022 Ye R, O'Callaghan C, Rua C, Hezemans FH, Holland N, Malpetti M, Jones PS, Barker RA, Williams-Gray CH, Robbins TW, Passamonti L, Rowe J. Locus Coeruleus Integrity from 7 T MRI Relates to Apathy and Cognition in Parkinsonian Disorders. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 35576973 DOI: 10.1002/mds.29072  0.395
2022 Hezemans FH, Wolpe N, O'Callaghan C, Ye R, Rua C, Jones PS, Murley AG, Holland N, Regenthal R, Tsvetanov KA, Barker RA, Williams-Gray CH, Robbins TW, Passamonti L, Rowe JB. Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes. Plos Computational Biology. 18: e1010079. PMID 35533200 DOI: 10.1371/journal.pcbi.1010079  0.488
2021 O'Callaghan C, Hezemans FH, Ye R, Rua C, Jones PS, Murley AG, Holland N, Regenthal R, Tsvetanov KA, Wolpe N, Barker RA, Williams-Gray CH, Robbins TW, Passamonti L, Rowe JB. Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease. Brain : a Journal of Neurology. PMID 33783470 DOI: 10.1093/brain/awab142  0.435
2020 Langley C, Gregory S, Osborne-Crowley K, O'Callaghan C, Zeun P, Lowe J, Johnson EB, Papoutsi M, Scahill RI, Rees G, Tabrizi SJ, Robbins TW, Sahakian BJ. Fronto-striatal circuits for cognitive flexibility in far from onset Huntington's disease: evidence from the Young Adult Study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 33130575 DOI: 10.1136/jnnp-2020-324104  0.45
2020 Scahill RI, Zeun P, Osborne-Crowley K, Johnson EB, Gregory S, Parker C, Lowe J, Nair A, O'Callaghan C, Langley C, Papoutsi M, McColgan P, Estevez-Fraga C, Fayer K, Wellington H, et al. Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis. The Lancet. Neurology. 19: 502-512. PMID 32470422 DOI: 10.1016/S1474-4422(20)30143-5  0.451
2020 O'Brien J, Taylor JP, Ballard C, Barker RA, Bradley C, Burns A, Collerton D, Dave S, Dudley R, Francis P, Gibbons A, Harris K, Lawrence V, Leroi I, McKeith I, et al. Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32213570 DOI: 10.1136/Jnnp-2019-322702  0.389
2020 Walpola IC, Muller AJ, Hall JM, Andrews-Hanna JR, Irish M, Lewis SJG, Shine JM, O'Callaghan C. Mind-wandering in Parkinson's disease hallucinations reflects primary visual and default network coupling. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 125: 233-245. PMID 32058090 DOI: 10.1016/J.Cortex.2019.12.023  0.394
2020 Powell A, Muller AJ, O'Callaghan C, Sourty M, Shine JM, Lewis SJG. Dopamine and Functional Connectivity in Patients With Parkinson's Disease and Visual Hallucinations. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32034927 DOI: 10.1002/Mds.27995  0.341
2019 Mariano LI, O'Callaghan C, Guimarães HC, Gambogi LB, da Silva TBL, Yassuda MS, Amaral JS, Caramelli P, Hornberger M, Teixeira AL, de Souza LC. Disinhibition in Frontotemporal Dementia and Alzheimer's Disease: A Neuropsychological and Behavioural Investigation. Journal of the International Neuropsychological Society : Jins. 1-9. PMID 31543087 DOI: 10.1017/S1355617719000973  0.342
2019 Heath CJ, O'Callaghan C, Mason SL, Phillips BU, Saksida LM, Robbins TW, Barker RA, Bussey TJ, Sahakian BJ. A Touchscreen Motivation Assessment Evaluated in Huntington's Disease Patients and R6/1 Model Mice. Frontiers in Neurology. 10: 858. PMID 31447770 DOI: 10.3389/Fneur.2019.00858  0.625
2018 Muller AJ, Mills JMZ, O'Callaghan C, Naismith SL, Clouston PD, Lewis SJG, Shine JM. Informant- and Self-Appraisals on the Psychosis and Hallucinations Questionnaire (PsycH-Q) Enhances Detection of Visual Hallucinations in Parkinson's Disease. Movement Disorders Clinical Practice. 5: 607-613. PMID 30637281 DOI: 10.1002/Mdc3.12683  0.36
2018 Jalal B, Brühl A, O'Callaghan C, Piercy T, Cardinal RN, Ramachandran VS, Sahakian BJ. Novel Smartphone Interventions Improve Cognitive Flexibility and Obsessive-Compulsive Disorder Symptoms in Individuals with Contamination Fears. Scientific Reports. 8: 14923. PMID 30353111 DOI: 10.1038/S41598-018-33142-2  0.656
2018 O'Callaghan C, Vaghi MM, Brummerloh B, Cardinal RN, Robbins TW. Impaired awareness of action-outcome contingency and causality during healthy ageing and following ventromedial prefrontal cortex lesions. Neuropsychologia. PMID 29355648 DOI: 10.1016/J.Neuropsychologia.2018.01.021  0.633
2017 O'Callaghan C, Lewis SJG. Cognition in Parkinson's Disease. International Review of Neurobiology. 133: 557-583. PMID 28802933 DOI: 10.1016/Bs.Irn.2017.05.002  0.431
2017 Gellersen HM, Guo CC, O'Callaghan C, Tan RH, Sami S, Hornberger M. Cerebellar atrophy in neurodegeneration-a meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28501823 DOI: 10.1136/Jnnp-2017-315607  0.381
2017 Muller AJ, O'Callaghan C, Walton CC, Shine JM, Lewis SJ. Retrospective Neuropsychological Profile of Patients With Parkinson Disease Prior to Developing Visual Hallucinations. Journal of Geriatric Psychiatry and Neurology. 891988716686830. PMID 28067106 DOI: 10.1177/0891988716686830  0.408
2017 Mariano LI, Guimaraes HC, Gambogi LB, Hornberger M, O'Callaghan C, Lima-Silva TB, Yassuda MS, Amaral JS, Teixeira AL, Caramelli P, Cruz de Souza L. [P4-291]: BEHAVIOURAL BUT NOT COGNITIVE MEASURES OF DISINHIBITION CAN EFFECTIVELY DIFFERENTIATE FRONTOTEMPORAL DEMENTIA FROM ALZHEIMER's DISEASE Alzheimer's & Dementia. 13: P1399-P1399. DOI: 10.1016/J.Jalz.2017.06.2160  0.365
2016 O'Callaghan C, Kveraga K, Shine JM, Adams RB, Bar M. Convergent evidence for top-down effects from the "predictive brain". The Behavioral and Brain Sciences. 39: e254. PMID 28355846 DOI: 10.1017/S0140525X15002599  0.316
2016 Hall JM, Ehgoetz Martens KA, Walton CC, O'Callaghan C, Keller PE, Lewis SJ, Moustafa AA. Diffusion alterations associated with Parkinson's disease symptomatology: A review of the literature. Parkinsonism & Related Disorders. PMID 27765426 DOI: 10.1016/J.Parkreldis.2016.09.026  0.394
2016 Bertoux M, O'Callaghan C, Dubois B, Hornberger M. In two minds: executive functioning versus theory of mind in behavioural variant frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 87: 231-4. PMID 26492929 DOI: 10.1136/Jnnp-2015-311643  0.36
2015 Shine JM, Mills JMZ, Qiu J, O'Callaghan C, Terpening Z, Halliday GM, Naismith SL, Lewis SJG. Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease. Movement Disorders Clinical Practice. 2: 175-181. PMID 30363832 DOI: 10.1002/Mdc3.12139  0.358
2015 Szeto JY, O'Callaghan C, Shine JM, Walton CC, Mowszowski L, Naismith SL, Halliday GM, Lewis SJ. The relationships between mild cognitive impairment and phenotype in Parkinson's disease. Npj Parkinson's Disease. 1: 15015. PMID 28725684 DOI: 10.1038/Npjparkd.2015.15  0.433
2015 Walton CC, O'Callaghan C, Hall JM, Gilat M, Mowszowski L, Naismith SL, Burrell JR, Shine JM, Lewis SJ. Antisaccade errors reveal cognitive control deficits in Parkinson's disease with freezing of gait. Journal of Neurology. PMID 26464101 DOI: 10.1007/S00415-015-7910-5  0.364
2015 Shine JM, Keogh R, O'Callaghan C, Muller AJ, Lewis SJ, Pearson J. Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson's disease and visual hallucinations. Proceedings. Biological Sciences / the Royal Society. 282: 20142047. PMID 25429016 DOI: 10.1098/Rspb.2014.2047  0.321
2015 Bell PT, Gilat M, O'Callaghan C, Copland DA, Frank MJ, Lewis SJ, Shine JM. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease. Human Brain Mapping. 36: 1278-91. PMID 25425542 DOI: 10.1002/Hbm.22701  0.385
2015 Walton CC, Shine JM, Mowszowski L, Gilat M, Hall JM, O'Callaghan C, Naismith SL, Lewis SJ. Impaired cognitive control in Parkinson's disease patients with freezing of gait in response to cognitive load. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 653-60. PMID 25047910 DOI: 10.1007/S00702-014-1271-6  0.331
2014 O'Callaghan C, Shine JM, Lewis SJ, Hornberger M. Neuropsychiatric symptoms in Parkinson's disease: fronto-striatal atrophy contributions. Parkinsonism & Related Disorders. 20: 867-72. PMID 24866458 DOI: 10.1016/J.Parkreldis.2014.04.027  0.329
2014 Kamminga J, O'Callaghan C, Hodges JR, Irish M. Differential prospective memory profiles in frontotemporal dementia syndromes. Journal of Alzheimer's Disease : Jad. 38: 669-79. PMID 24056089 DOI: 10.3233/Jad-131118  0.312
2014 O'Callaghan C, Bertoux M, Hornberger M. Beyond and below the cortex: the contribution of striatal dysfunction to cognition and behaviour in neurodegeneration. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 371-8. PMID 23833269 DOI: 10.1136/Jnnp-2012-304558  0.444
2013 O'Callaghan C, Moustafa AA, de Wit S, Shine JM, Robbins TW, Lewis SJ, Hornberger M. Fronto-striatal gray matter contributions to discrimination learning in Parkinson's disease. Frontiers in Computational Neuroscience. 7: 180. PMID 24376416 DOI: 10.3389/Fncom.2013.00180  0.48
2013 Kloeters S, Bertoux M, O'Callaghan C, Hodges JR, Hornberger M. Money for nothing - Atrophy correlates of gambling decision making in behavioural variant frontotemporal dementia and Alzheimer's disease. Neuroimage. Clinical. 2: 263-72. PMID 24179781 DOI: 10.1016/J.Nicl.2013.01.011  0.337
2013 O'Callaghan C, Naismith SL, Shine JM, Bertoux M, Lewis SJ, Hornberger M. A novel bedside task to tap inhibitory dysfunction and fronto-striatal atrophy in Parkinson's disease. Parkinsonism & Related Disorders. 19: 827-30. PMID 23680420 DOI: 10.1016/J.Parkreldis.2013.04.020  0.442
2013 O'Callaghan C, Naismith SL, Hodges JR, Lewis SJ, Hornberger M. Fronto-striatal atrophy correlates of inhibitory dysfunction in Parkinson's disease versus behavioural variant frontotemporal dementia. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 49: 1833-43. PMID 23306064 DOI: 10.1016/J.Cortex.2012.12.003  0.393
Show low-probability matches.